S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

West Pharmaceutical Services Stock Forecast, Price & News

+5.37 (+1.78%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
319,083 shs
Average Volume
407,418 shs
Market Capitalization
$22.80 billion
P/E Ratio
Dividend Yield
Price Target

West Pharmaceutical Services MarketRank™ Forecast

Analyst Rating
3.00 Rating Score
54.4% Upside
$475.00 Price Target
Short Interest
1.04% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
Insider Trading
Proj. Earnings Growth
From $9.33 to $10.30 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.51 out of 5 stars

Medical Sector

84th out of 1,428 stocks

Fabricated Rubber Products, Not Elsewhere Classified Industry

2nd out of 3 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

West Pharmaceutical Services logo

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock News Headlines

S&P 500 Analyst Moves: WST
West Pharmaceutical Services is Oversold
West Announces Executive Leadership Appointments
West to Host First-Quarter 2022 Conference Call
See More Headlines

Industry, Sector and Symbol

Fabricated rubber products, not elsewhere classified
Health Care Supplies
Year Founded

Company Calendar

Ex-Dividend for 5/4 Dividend
Last Earnings
Dividend Payable
Ex-Dividend for 8/3 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
$661.80 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.83 billion
Cash Flow
$10.47 per share
Book Value
$31.44 per share


Free Float
Market Cap
$22.80 billion

Social Links

West Pharmaceutical Services Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" West Pharmaceutical Services stock.
View analyst ratings for West Pharmaceutical Services
or view top-rated stocks.

What is West Pharmaceutical Services' stock price forecast for 2022?

2 Wall Street analysts have issued 1 year price objectives for West Pharmaceutical Services' stock. Their WST stock forecasts range from $475.00 to $475.00. On average, they expect West Pharmaceutical Services' share price to reach $475.00 in the next twelve months. This suggests a possible upside of 54.4% from the stock's current price.
View analysts' price targets for West Pharmaceutical Services
or view top-rated stocks among Wall Street analysts.

How has West Pharmaceutical Services' stock performed in 2022?

West Pharmaceutical Services' stock was trading at $469.01 at the beginning of the year. Since then, WST stock has decreased by 34.4% and is now trading at $307.74.
View the best growth stocks for 2022 here

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a drop in short interest in May. As of May 31st, there was short interest totaling 728,100 shares, a drop of 14.4% from the May 15th total of 850,700 shares. Based on an average daily trading volume, of 423,300 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.0% of the shares of the stock are short sold.
View West Pharmaceutical Services' Short Interest

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for West Pharmaceutical Services

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings results on Thursday, April, 28th. The medical instruments supplier reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.18 by $0.12. The medical instruments supplier had revenue of $720 million for the quarter, compared to analysts' expectations of $720.92 million. West Pharmaceutical Services had a net margin of 23.76% and a trailing twelve-month return on equity of 30.33%. The business's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.05 EPS.
View West Pharmaceutical Services' earnings history

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, April 28th. Shareholders of record on Wednesday, July 20th will be given a dividend of $0.18 per share on Wednesday, August 3rd. This represents a $0.72 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date is Tuesday, July 19th.
View West Pharmaceutical Services' dividend history

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services(NYSE:WST) pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.23%. West Pharmaceutical Services has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of West Pharmaceutical Services is 8.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 6.99% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.
View West Pharmaceutical Services' dividend history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $9.30-$9.45 for the period, compared to the consensus estimate of $9.28. The company issued revenue guidance of $3.05 billion-$3.08 billion, compared to the consensus revenue estimate of $3.07 billion.

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the following people:
  • Mr. Eric M. Green, Pres, CEO & Director (Age 52, Pay $3.42M)
  • Mr. Bernard J. Birkett, Sr. VP & CFO (Age 53, Pay $1.5M)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 57, Pay $1.08M) (LinkedIn Profile)
  • Mr. Silji Abraham, Sr. VP & Chief Technology Officer (Age 50, Pay $1.11M) (LinkedIn Profile)
  • Ms. Kimberly Banks MacKay, Sr. VP, Gen. Counsel & Company Sec. (Age 56, Pay $946.43k)
  • Mr. Chad R. Winters, VP, Chief Accounting Officer & Corp. Controller (Age 43)
  • Dr. Quintin J. Lai C.F.A., Ph.D., VP of Strategy & Investor Relations (Age 55)
  • Michele Polinsky, VP of Global Communications
  • Ms. Annette F. Favorite, Chief HR Officer & Sr. VP (Age 57) (LinkedIn Profile)
  • Mr. Richard D. Luzzi, Sr. VP of HR (Age 70)

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services CEO Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among West Pharmaceutical Services' employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $307.74.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services (NYSE:WST) has a market capitalization of $22.80 billion and generates $2.83 billion in revenue each year. The medical instruments supplier earns $661.80 million in net income (profit) each year or $9.00 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

West Pharmaceutical Services employs 10,065 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?

The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More

When was West Pharmaceutical Services founded?

West Pharmaceutical Services was founded in 1923.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for West Pharmaceutical Services is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.

This page (NYSE:WST) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.